Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 329
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00593866 | Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer | ||
| NCT06047626 | Living Well With Lymphoma | ||
| NCT00151060 | Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate | ||
| NCT04480541 | A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients | ||
| NCT00599131 | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) | ||
| NCT06539468 | Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients | ||
| NCT06641310 | Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP) | ||
| NCT02059213 | A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer | ||
| NCT00637390 | A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. | ||
| NCT00176761 | Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine | ||
| NCT04845035 | Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia | ||
| NCT05867667 | Cardiac Rehabilitation to Improve Breast Cancer Outcomes | ||
| NCT00146055 | Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood | ||
| NCT00320749 | Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer | ||
| NCT06915168 | CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer | ||
| NCT00176735 | Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer | ||
| NCT04503668 | Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients | ||
| NCT00142571 | Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma | ||
| NCT03787680 | Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) | ||
| NCT03785873 | Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer | ||
| NCT01663246 | Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer | ||
| NCT00151047 | Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer | ||
| NCT03601819 | Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders | ||
| NCT00480857 | Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy | ||
| NCT03352427 | Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations | ||
| NCT00565227 | Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. | ||
| NCT00156286 | Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC | ||
| NCT04848337 | Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer | ||
| NCT06225427 | Gilteritinib for the Treatment of ALK NSCLC | ||
| NCT00639717 | Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant | ||
| NCT00858585 | Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study | ||
| NCT03781986 | APG-115 in Salivary Gland Cancer Trial | ||
| NCT02138578 | Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma | ||
| NCT00148122 | A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer | ||
| NCT03099356 | Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer | ||
| NCT02958787 | Vessel Sparing Prostate Radiation Therapy | ||
| NCT00136487 | Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer | ||
| NCT01986738 | A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer | ||
| NCT01988675 | MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier | ||
| NCT00064272 | UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer | ||
| NCT03570619 | Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations | ||
| NCT04094844 | Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation | ||
| NCT02338115 | Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients | ||
| NCT02496260 | Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy | ||
| NCT00581256 | A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer | ||
| NCT00955188 | Computer-Based Tailored or Standard Information for Colorectal Cancer Screening | ||
| NCT02679586 | Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy | ||
| NCT03235869 | Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma | ||
| NCT04140162 | Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy | ||
| NCT00151073 | Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate |
